LMLuis A. Milla

Luis A. Milla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luis A. Milla has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecules involved in the sperm interaction in the human uterine tube: a histochemical and immunohistochemical approach

    by David Cajas, Emanuel Guajardo, Sergio Jara-Rosales, Claudio Nuñez, Renato Vargas, Victor Carriel, Antonio Campos, Luis Milla, Pedro Orihuela, Carlos Godoy-Guzman

    In humans, even where millions of spermatozoa are deposited upon ejaculation in the vagina, only a few thousand enter the uterine tube (UT). Sperm transiently adhere to the epithelial cells lining the isthmus reservoir, and this interaction is essential in coordinating the availability of functional spermatozoa for fertilization. The binding of spermatozoa to the UT epithelium (mucosa) occurs due to interactions between cell-adhesion molecules on the cell surfaces of both the sperm and the epithelial cell. However, in humans, there is little information about the molecules involved. The aim of this study was to perform a histological characterization of the UT focused on determining the tissue distribution and deposition of some molecules associated with cell adhesion (F-spondin, galectin-9, osteopontin, integrin αV/β3) and UT’s contractile activity (TNFα-R1, TNFα-R2) in the follicular and luteal phases. Our results showed the presence of galectin-9, F-spondin, osteopontin, integrin αV/β3, TNFα-R1, and TNFα-R2 in the epithelial cells in ampullar and isthmic segments during the menstrual cycle. Our results suggest that these molecules could form part of the sperm-UT interactions. Future studies will shed light on the specific role of each of the identified molecules.


  • Open Access

    P2X7 receptor is essential for cross-dressing of bone marrow-derived dendritic cells

    by Carlos Barrera-Avalos, Pedro Briceño, Daniel Valdés, Mónica Imarai, Elías Leiva-Salcedo, Leonel E. Rojo, Luis A. Milla, Juan Pablo Huidobro-Toro, Claudia Robles-Planells, Alejandro Escobar, et al.


  • Open Access

    Anthocyanins from Aristotelia chilensis Prevent Olanzapine-Induced Hepatic-Lipid Accumulation but Not Insulin Resistance in Skeletal Muscle Cells

    by Andrea del Campo, Catalina Salamanca, Angelo Fajardo, Francisco Díaz-Castro, Catalina Bustos, Camila Calfío, Rodrigo Troncoso, Edgar R. Pastene-Navarrete, Claudio Acuna-Castillo, Luis A. Milla, et al.

    Type 2 diabetes and obesity are major problems worldwide and dietary polyphenols have shown efficacy to ameliorate signs of these diseases. Anthocyanins from berries display potent antioxidants and protect against weight gain and insulin resistance in different models of diet-induced metabolic syndrome. Olanzapine is known to induce an accelerated form of metabolic syndrome. Due to the aforementioned, we evaluated whether delphinidin-3,5-O-diglucoside (DG) and delphinidin-3-O-sambubioside-5-O-glucoside (DS), two potent antidiabetic anthocyanins isolated from Aristotelia chilensis fruit, could prevent olanzapine-induced steatosis and insulin resistance in liver and skeletal muscle cells, respectively. HepG2 liver cells and L6 skeletal muscle cells were co-incubated with DG 50 μg/mL or DS 50 μg/mL plus olanzapine 50 μg/mL. Lipid accumulation was determined in HepG2 cells while the expression of p-Akt as a key regulator of the insulin-activated signaling pathways, mitochondrial function, and glucose uptake was assessed in L6 cells. DS and DG prevented olanzapine-induced lipid accumulation in liver cells. However, insulin signaling impairment induced by olanzapine in L6 cells was not rescued by DS and DG. Thus, anthocyanins modulate lipid metabolism, which is a relevant factor in hepatic tissue, but do not significantly influence skeletal muscle, where a potent antioxidant effect of olanzapine was found.


  • Adenosine Triphosphate, Polymyxin B and B16 Cell-Derived Immunization Induce Anticancer Response

    by Carlos Barrera-Avalos, Javier Mena, Ximena López, Claudio Cappelli, Tanya Neira, Mónica Imarai, Ricardo Fernández, Claudia Robles-Planells, Leonel E Rojo, Luis A Milla, et al.

    Aim: Whole dead tumor cells can be used as antigen source and the induction of protective immune response could be enhanced by damage-associated molecular patterns. Materials & methods: We generate...


  • Open Access

    In Vivo Antitumor Effect against Murine Cells of CT26 Colon Cancer and EL4 Lymphoma by Autologous Whole Tumor Dead Cells

    by Carlos Barrera-Avalos, Ximena Díaz, Bastián Madrid, Sofía A. Michelson, Claudia Robles-Planells, Giselle Sánchez-Guerrero, Viviana Ahumada, Andrea Mella-Torres, Leonel E. Rojo, Mónica Imarai, et al.

    Active immunotherapy against cancer is based on immune system stimulation, triggering efficient and long‐lasting antigen‐specific immune responses. Immunization strategies using whole dead cells from tumor tissue, containing specific antigens inside, have become a promising approach, providing efficient lymphocyte activation through dendritic cells (DCs). In this work, we generate whole dead tumor cells from CT26, E.G7, and EL4 live tumor cells as antigen sources, which termed immunogenic cell bodies (ICBs), generated by a simple and cost‐efficient starvation‐protocol, in order to determine whether are capable of inducing a transversal anticancer response regardless of the tumor type, in a similar way to what we describe previously with B16 melanoma. We evaluated the anticancer effects of immunization with doses of ICBs in syngeneic murine tumor models. Our results showed that mice’s immunization with ICBs‐E.G7 and ICBs‐CT26 generate 18% and 25% of tumor‐free animals, respectively. On the other hand, all carrying tumor‐animals and immunized with ICBs, including ICBs‐EL4, showed a significant delay in their growth compared to not immunized animals. These effects relate to DCs maturation, cytokine production, increase in CD4+T‐bet+ and CD4+ROR‐γt+ population, and decrease of T regulatory lymphocytes in the spleen. Altogether, our data suggest that whole dead tumor cell‐based cancer immunotherapy generated by a simple starvation protocol is a promising way to develop complementary, innovative, and affordable antitumor therapies in a broad spectrum of tumors.


  • Open Access

    Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies

    by Claudia Robles-Planells, Giselle Sánchez-Guerrero, Carlos Barrera-Avalos, Silvia Matiacevich, Leonel E. Rojo, Jorge Pavez, Edison Salas-Huenuleo, Marcelo J. Kogan, Alejandro Escobar, Luis A. Milla, et al.

    Oncolytic virus therapy has been tested against cancer in preclinical models and clinical assays. Current evidence shows that viruses induce cytopathic effects associated with fusogenic protein-mediated syncytium formation and immunogenic cell death of eukaryotic cells. We have previously demonstrated that tumor cell bodies generated from cells expressing the fusogenic protein of the infectious salmon anemia virus (ISAV-F) enhance crosspriming and display prophylactic antitumor activity against melanoma tumors. In this work, we evaluated the effects of the expression of ISAV-F on the B16 melanoma model, both in vitro and in vivo, using chitosan nanoparticles as transfection vehicle. We confirmed that the transfection of B16 tumor cells with chitosan nanoparticles (NP-ISAV) allows the expression of a fusogenically active ISAV-F protein and decreases cell viability because of syncytium formation in vitro. However, the in vivo transfection induces a delay in tumor growth, without inducing changes on the lymphoid populations in the tumor and the spleen. Altogether, our observations show that expression of ISAV fusion protein using chitosan nanoparticles induces cell fusion in melanoma cells and slight antitumor response.


  • Open Access

    Chitosan‐Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene: In Vitro and In Vivo Studies towards a New Vaccine against Melanoma

    by Claudia Robles-Planells, Carlos Barrera-Avalos, Leonel E. Rojo, Eugenio Spencer, Marcelo Cortez-San Martin, Silvia Matiacevich, Jorge Pavez, Luis A. Milla, Franco D. Navarro, Brandon A. Martínez, et al.

    Reovirus is known to have an anticancer effect in both the preclinical and clinical assays. Current evidence suggests that the reovirus‐mediated impact on tumor growth depends on the activation of specific antitumor immune responses. A feasible explanation for the oncolytic effects and immune system activation is through the expression of the fusogenic reovirus protein. In this work, we evaluated the in vivo antitumor effects of the expression of fusogenic protein p10 of avian reovirus (ARV‐p10). We used chitosan nanoparticles (CH‐NPs) as a vehicle for the ARV‐p10 DNA in murine B16 melanoma models both in vitro and in vivo. We confirmed that ARV‐p10 delivery through a chitosan‐based formulation (ARV‐p10 CH‐NPs) was capable of inducing cell fusion in cultured melanoma cells, showing a mild cytotoxic effect. Interestingly, intratumor injection of ARV‐p10 CH‐NPs delayed tumor growth, without changing lymphoid populations in the tumor tissue and spleen. The injection of chitosan nanoparticles (CH‐NPs) also delayed tumor growth, suggesting the nanoparticle itself would attack tumor cells. In conclusion, we proved that in vitro ARV‐p10 protein expression using CH‐NPs in murine melanoma cells induces a cytotoxic effect associated with its cell fusion. Further studies are necessary for establishing a protocol for efficient in vivo DNA delivery of fusion proteins to produce an antitumoral effect.


  • Early postnatal environmental enrichment restores neurochemical and functional plasticities of the cerebral cortex and improves learning performance in hidden-prenatally-malnourished young-adult rats

    by Héctor Burgos, Alejandro Hernández, Luis Constandil, Miguel Ríos, Osvaldo Flores, Gustavo Puentes, Karina Hernández, Carlos Morgan, Luis Valladares, Amparo Castillo, et al.


  • Open Access

    The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration

    by Andrea A. Villanueva, Paulina Falcón, Natalie Espinoza, Luis Solano R., Luis A. Milla, Esther Hernandez-SanMiguel, Vicente A. Torres, Pilar Sanchez-Gomez, Verónica Palma

    The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration


  • Abstract B50: Neogenin-1 promotes cell migration, survival, and metastasis through Netrin-4 in neuroblastoma cells

    by Andrea Villanueva, Natalie Andrea Espinoza, Luis Solano, Luis Milla, Veronica Palma

    Neogenin-1, a transmembrane receptor involved in axonal guidance, angiogenesis, neuronal cell migration, and cell death, is activated when bound to the Netrin and RGM ligand families during development and adult homeostasis. While Neogenin-1 and its ligands have been shown to be involved in tumoral progression, little is known about the specific function of the proteins and the cell signaling events that occur in cancer cells. Here, we demonstrate the exclusive presence of Neogenin-1 and Netrin-4 in SK-N-SH and SH-SY5Y neuroblastoma cells. Our research elucidates the function of Neogenin-1 and its autocrine ligand Netrin-4 in cell migration, proliferation, survival, and metastasis, the cellular aspects of cancer. To evaluate the contribution of Neogenin-1, the protein was knocked down using shRNAs (shNeo1) and overexpressed. We also knocked down Netrin-4 with shRNA (shNTN4) and performed gain of function studies using a human recombinant of this protein. Cell migration was analyzed via wound healing and transwell assays using increasing concentrations of Netrin-4. In addition, we evaluated cell proliferation and cell apoptosis after treatments. We also assessed metastasis and tumoral progression via chick chorioallantoic membrane (CAM) assay and quantitative-PCR to evaluate presence of human Alu sequences in genomic DNA extracted from chick embryonic lungs. We observed that shNeo1 and shNTN4 cells migrate less in transwell assays, possibly due to their insensibility to the chemotactic stimuli of Netrin-4. shNeo1 cells migrated less in wound healing assays as well. We detected increased cell migration when overexpressing Neogenin-1, but observed that cells were insensible to the Netrin-4 stimulus when overexpressing only the intracellular domain of Neogenin-1. We found less proliferation of shNTN4 cells in comparison to control cells, indicating that endogenous expression of Netrin-4 is required. This may be the case if Netrin-4 acts as a survival factor via its receptor Neogenin-1. Additionally, we observed increased cell death when knocking down Netrin-4 and that exogenous Netrin-4 was able to reduce this effect. Also, when Neogenin-1 is overexpressed, cell death increases and Netrin-4 is able to rescue cells from apoptosis. Finally, in vivo analysis showed that the weight of primary tumors in shSCR (control), shNeo1, and shNetrin-4 cells are similar. However, shNeo1 and shNTN4 did not produce secondary tumors. Metastasis analysis indicated that shNeo1 and shNTN4 metastasize less than control cells. Overall these results demonstrate that Neogenin-1 is involved in cell migration via Netrin-4 in neuroblastoma cells, and that endogenous Netrin-4 is important for cell survival, as it reduces apoptosis induced by Neogenin-1. We demonstrate that the Neogenin-1/Netrin-4 signaling complex modulates metastasis of neuroblastoma cells: Netrin-4 induces cell migration when bound to Neogenin-1, and conversely mediates apoptosis when not bound to Neogenin-1. Thus, endogenous Netrin-4 maintains the cells in a pro-survival and pro-migratory state. Our results shed light on the cellular mechanics of Netrin-4 and its receptor, Neogenin-1, which provides further information on their potential use as therapeutic targets to reduce metastasis in neuroblastoma. Citation Format: Andrea Villanueva, Natalie Andrea Espinoza, Luis Solano, Luis Milla, Veronica Palma. Neogenin-1 promotes cell migration, survival, and metastasis through Netrin-4 in neuroblastoma cells. [abstract]. In: Proceedings of the AACR Special Conference on Tumor Metastasis; 2015 Nov 30-Dec 3; Austin, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(7 Suppl):Abstract nr B50.